Mode
Text Size
Log in / Sign up
Phase 3 N=48 Randomized Single-blind Treatment

Effectiveness of Mirror Therapy in Stroke Patients With Unilateral Neglect - A Randomized Controlled Trial

Hemispatial Neglect

Enrolled (actual)
48
Serious AEs
0.0%
Results posted
Jun 2014
Primary outcome: Primary: Change From Baseline in Star Cancellation Test Scores at 1,3, and 6 Months — 17.88; 18.20; 20.03; 5.90 units on a scale — p=0.77

Study Design & Population

Study type
Interventional
Phase
Phase 3
Interventions
Mirror therapy (Other); Control group (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Christian Medical College and Hospital, Ludhiana, India
Primary completion
Jul 2013

Outcome Measures

OutcomeResultp-value
PRIMARY
Change From Baseline in Star Cancellation Test Scores at 1,3, and 6 Months
17.88; 18.20; 20.03; 5.90; 31.76; 9.2 0.77
PRIMARY
Change From Baseline in Line Bisection Test Scores at 1,3, and 6 Months
2.28; 0.45; 10.42; 4.50; 18.26; 9.55 0.64
PRIMARY
Change From Baseline in Picture Identification Task at 1,3, and 6 Months
4.84; 4.20; 4.88; 1.2; 5.16; 1.75 0.99
SECONDARY
Functional Independence Measure
27; 21; 26; 20; 18; 19 0.99
SECONDARY
Modified Rankin Scale (mRS)
27; 21; 25; 20; 16; 19 0.99

Summary

Hemi spatial neglect, or the tendency to ignore stimuli originating in a portion of the environment contra lateral to a cerebral lesion, can be a major source of functional handicap after stroke. The currently available treatments for unilateral neglect are scanning training, visual cuing approaches, limb activation strategies, visual imagery, tactile stimulation, prisms and sustained attention training.Mirror therapy improves the hand function in sub-acute stroke. Hypothesis: To evaluate the effectiveness of Mirror therapy in the management of stroke patients with unilateral neglect.

Eligibility Criteria

Inclusion Criteria: 1.All stroke patients with parietal lobe and thalamic lesions 2. Stroke duration: within 48 hours 3. Patients willing to participate in the study 4. MRI/ CT scan showing parietal lobe and thalamic lesion 5. Patients with upper limb weakness

Exclusion Criteria

  • Stroke duration more than 1 yr
  • Glasgow Coma Scale (GCS) of less than 7
  • Uncooperative patients
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01735877). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search